Rosuvastatin zinc

This classification denotes a hmg-coa reductase inhibitor 2C22H27FN3O6S.Zn, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70VE4E19Z7, chemically known as 6-heptenoic acid, 7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-, zinc salt (2:1), (3r,5s,6e)-, but more generally known as rosuvastatin zinc, which bears US NIH Compound Identifier 56842257. Most nations, for tariff and trade purposes, schedule rosuvastatin zinc under HS 29350090 and SITC 51580. As of Q4 2014, ROSUVASTATIN ZINC remains US FDA's Preferred Term for this commodity. Rosuvastatin zinc bears US NLM identifiers UMLS ID C3272708 and NCI Concept Code C96308. SMILES: CC(C1NC(NC(C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2CCC(CC2)F)N(S(=O)(=O)C)C)C.CC(C1NC(NC(C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C2CCC(CC2)F)N(S(=O)(=O)C)C)C.[ZN+2].